Viewing StudyNCT00217555



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217555
Status: COMPLETED
Last Update Posted: 2010-09-21
First Post: 2005-09-20

Brief Title: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian Fallopian Tube or Primary Peritoneal Cavity Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Peritoneal Cavity Cancer
Fallopian Tube Cancer
Ovarian Cancer
Keywords:
Name View
peritoneal cavity cancer View
recurrent ovarian epithelial cancer View
fallopian tube cancer View